Equasens partnered with ARZ Haan, a German market leader for services and software solutions for healthcare providers. This partnership has acquired Apotheken Datenverabeitung (ADV) creating Pharmegest Germany. ARZ Haan have a holding of 6% whilst Equasens hold 94% allowing them to deploy their growth strategy in Germany.
ADV specialises in IT and software solutions for pharmacies as an independent software vendor. They are recognised in Germany for their high quality and range. This has allowed them to adapt their software solution perfectly to their market and to develop within the German healthcare sector which is having a transformation and leaning towards digital advancements.
Equasens specialises in the production of software solutions for the healthcare industry and is listed on Euronext Paris. Pharmagest Germany is going to invest and develop technology and technical building blocks along with a sales network which will reinforce ADV’s software offering.
LFR - Business Lawyers which are based in Munich advised ADV in the selling of their capital to Equasens.
LFR – Are you searching for trusted, experienced business representation in Germany
LFR - Business Lawyers which are based in Munich advised ADV with a team led by partner Dr. Christian Ruso and associate Tobias Kreth. The team advised ADV on all tax and corporate law aspects of the transaction, in particular regarding the structure of the SPA and the carve-out of subsidiaries.
